Comment
doi: 10.1126/sciimmunol.aaz8128.
A new perspective in cancer immunotherapy: PD-1 on myeloid cells takes center stage in orchestrating immune checkpoint blockade
Affiliations
- PMID: 31901075
- DOI: 10.1126/sciimmunol.aaz8128
Item in Clipboard
Comment
A new perspective in cancer immunotherapy: PD-1 on myeloid cells takes center stage in orchestrating immune checkpoint blockade
Sci Immunol.
.
Abstract
PD-1 mediates antitumor immunity by regulating lineage fate commitment and function of myeloid cells (see related Research Article by Strauss et al..).
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Comment on
-
Targeted deletion of PD-1 in myeloid cells induces antitumor immunity.Sci Immunol. 2020 Jan 3;5(43):eaay1863. doi: 10.1126/sciimmunol.aay1863. Sci Immunol. 2020. PMID: 31901074 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
